How the Clinical Laboratory Enhances Patient Care

advertisement
kscls
How the Clinical Laboratory
Enhances Patient Care
kcclma
Fred V. Plapp, MD PhD
Medical Director
Saint Luke’s Regional Laboratories
Diagnosis of Meningitis
kscls
Expediting Patient Care
Infection of tissues
surrounding the brain
& spinal cord
 Bacterial or viral

kcclma
◦ Mostly viral
Viral usually mild
 Bacterial is lifethreatening

Diagnosis of Meningitis
kscls
Traditional Practice
Patient presents to Emergency Room
 Lumbar puncture to collect CSF

◦ Bacterial cultures require 3 days
◦ Viral cultures require 10 days
kcclma
Patient admitted to hospital
 Treated with IV antibiotics until likely that
bacterial culture will be negative
 Discharged with outpatient antibiotics

kscls
Viral Meningitis
Traditional Diagnosis
kcclma
4 – 10
Days
kscls
Viral Meningitis
Real Time PCR Diagnosis
kcclma
1 million viral copies in 30 minutes
instead of 10 days
kscls
New Meningitis Algorithm
RT PCR while patient is in ER
kcclma
Enterovirus
Detected
Enterovirus
Not Detected
Discharge
Admit to Hospital
Meningitis Outcomes
kscls
Downstream Cost Savings

Traditional Approach
◦
◦
◦
◦
kcclma

Average LOS is 2.8 days
Average hospital charge is $14,050
IV antibiotics during admission
Outpatient antibiotics for 10 – 14 days
SLH Molecular Approach
◦ Avoid admission if Enterovirus detected
◦ Avoid unnecessary antibiotics
Rapid ID of CoNS
kscls
Improved Antibiotic Stewardship

Peptide Nucleic Acid FISH
◦ Non-amplified fluorescent molecular probe
 Recognizes species specific RNA
kcclma
◦ Distinguishes Coagulase Negative Staph from
Staph aureus
◦ Advantages
 Timely & accurate same day results
 Minimal equipment requirement
 Other probes for Gram-negatives & yeast
◦ Disadvantages
 Expensive cost per test
 Must batch test due to $$$$$
kscls
kcclma
Rapid ID of CoNS
Lab & Pharmacy Cost Savings
Culture
Alone
Culture +
PNA
Time to ID Antibiotic
Dose per
Patient
132 hours
5.8
38 hours
2.8
Cost per
Patient*
$72.02
$14.28
Cost per patient included antibiotics & laboratory tests
Rapid ID of CoNS
kscls
Downstream Cost Savings
SLHS performed 23,652 blood cultures in
2009
 452 contaminants (1.9%)

kcclma
◦ 350 were CoNS
Each contaminant adds ~$5000 to cost of
hospital stay
 Rapid ID of CoNS saves ~$1.75M per
year by preventing  LOS

Recombinant rFVIIa Usage
kscls
Laboratory as a Watchdog
Recombinant Factor VIIa (Novoseven)
 Binds directly to tissue factor & activates
FX
 FDA approved for hemophilia with
acquired inhibitor
 Off label use for acute bleeding 

kcclma
◦ Very expensive ( $1 per ug)
◦ Short half-life of 2-3 hours
◦ Possible thromboembolic events
kscls
Reining in the Outlier
Surgeon
kcclma
1Q09
1Q10
1
$5450
$0
2
$0
$0
3
$0
$0
4
$0
$12,220
5
$98,690
$16,000
Open Heart Surgery
kscls
Transfusion Review
OHS transfused ~one third of components
 Clinical Pathologist analyzed blood usage
each year

◦ Surgeon specific usage
◦ Reviewed with CTS team
◦ Evaluated risk factors, meds,practice variations
kcclma
Published transfusion guidelines & risks
 Presented to surgeons, Department Chair,
Chief Medical Officer

Average Number of Units
kscls
Transfused per OHS Case
4.5
kcclma
Average # Units per Patient
4
3.5
RBC
FFP
Platelets
3
2.5
2
1.5
1
0.5
0
1990 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
kscls
Benefits of Decreased Transfusion
$260,000 cost savings in blood
products per year
 Transfusion reaction risks decreased
 Blood Bank workload decreased
 Nursing time for transfusion
decreased

kcclma
Order Sets
kscls
Ensuring Appropriate Testing
Nurses & physicians write order sets
 Clinical Pathologists review lab tests

◦ Additions, deletions, substitutions
kcclma
Suggestions returned to authors
 Order sets published
 Test utilization monitored before & after

70 Order Sets
kscls
Impact on Test Utilization
kcclma
Year
Cases/Yr
Tests/Cs
Test/Yr
1992
8823
50.3
443,797
1996
9630
44.3
426,609
Diff
807
-6
-17,188
% Diff
+9%
-12%
-4%
kscls
kcclma
Inpatient Tests per Discharge
60
50
40
30
20
10
0
75th per centi l e
25th per centi l e
1Q94 1Q95 1Q96 1Q97 1Q98 1Q99 2Q00 1Q01 1Q02 1Q03 1Q04
Specimen in Lab Policy
kscls
Decreasing Wastage
Worked with Blood Management Team to
reduce iatrogenic blood loss
 SIL Policy implemented

kcclma
◦ Stored blood specimens for 1 week
◦ Publicized in Lab Letter & Nursing publications
◦ Avoided redrawing patients for add-on testing
Specimen in Lab Policy
kscls
SLH Outcomes
11,244 requests for tests on SIL
 $51,726 savings in labor & supplies
 Avoided 11,244 venipunctures
 Conserved 71,428 mL of blood

kcclma
◦ Equivalent to 140 units of RBCs
POC Blood Glucose Testing
kscls
Improving Patient Safety

Manual Patient ID entry
◦ 12,000 tests per month
◦ 9.7% average error rate
◦ ~450 unidentified results per month
kcclma

PI project to reduce errors
◦ Accu-Chek Inform & RALS Plus
◦ Barcoded armbands & handheld devices
nFe 02
bM 02
ar
-0
A 2
pr
M 02
ay
Ju 02
n0
Ju 2
lA 02
ug
S 02
ep
-0
O 2
ct
N 02
ov
D 02
ec
-0
Ja 2
nFe 03
bM 03
ar
-0
A 3
pr
M 03
ay
Ju 03
n0
Ju 3
lA 03
ug
S 03
ep
-0
O 3
ct
N 03
ov
D 03
ec
-0
3
Ja
kcclma
Error Rate %
kscls
Glucose Meter ID Errors
12.0
10.0
8.0
6.0
4.0
2.0
0.0
Test Utilization Ideas
kscls
kcclma
www.clinlabnavigator.com
Download